Translating Quality by Design Principles into Practice, Part 1
SHARE TO:
Webinar Objective
This webinar is the first in a CTTI-hosted series designed to provide real-world examples of applying QbD to clinical trials. Click here for more information about CTTI's QbD Project.
*The views and opinions expressed in this video are those of the speaker and do not necessarily reflect the official policy or position of CTTI.
Webinar Agenda
- CTTI Quality by Design Project Overview by Ann Meeker-O’Connell, Senior Director, Clinical Quality Strategy Team Lead, Janssen
- Pfizer Experience by Coleen Glessner, Vice President, Clinical Trial Process and Quality, Pfizer
- Seattle Genetics Experience by Marta Fields, Senior Director, Compliance and Quality Systems, Seattle Genetics
- Q&A
Watch Translating Quality by Design Principles into Practice, Part 2
Recent Webinars
- Artificial Intelligence in Drug & Biological Product Development Hybrid Public Workshop 2025 November 4, 2025
- CTTI’s Disease Progression Modeling Recommendations & Tool Launch July 8, 2025
- TransCelerate BioPharma Presents Risk Based Monitoring Initiative to CTTI Members October 10, 2024
- Translating Quality by Design Principles into Practice, Part 1 October 10, 2024
- Optimizing Mobile Clinical Trials by Engaging Patients and Sites October 10, 2024
- Results of National Public Poll on Clinical Trials October 10, 2024
- Quality by Design – From Concept to Implementation and Beyond October 10, 2024